The Law of the Vital Few

Recommended Stock Newsletters
 
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder


Penny Doctor Newsletter

Template Having trouble viewing this email “%%webversion%%” https://app.getresponse..com/view.htmlx=a62b&m=aUS6&mc=B1&s=rWw5L&u=TgO&y=j& Fellow Trader, First, I hope you had a nice long weekend. The markets was closed yesterday and hopefully you have a day off (or as close to it as it gets when you are an active trader).

My scanners remain active and my search goes on. There are plenty of companies crossing my desk. In fact, I have one for you tonight Make sure you reply to this email so I know you’re in.


Last week we started the New Year off with CGRA and so far so good! Some of you have been long term members others may have recently joined, to all of you I say thank you and we appreciate you being a member. If you missed any of my previous newsletters and would like a copy, please request a copy by reply to this email with your request.

Now I would like to share with you some information you may find interesting, it`s called the Vital Few Law, also known as Pareto’s Principle. It’s probably one of the most interesting things from the management classes we all had (or might have had).  The Pareto principle (also known as the 80–20 rule, the law of the vital few, and the principle of factor sparsity) states that, for many events, roughly 80% of the effects come from 20% of the causes. Source:

https://app.getresponse.com/click.htmlx=a62b&lc=BYlDV&mc=B1&s=rWw5L&u=TgO&y=N& “https://app.getresponse.com/click.htmlx=a62b&lc=BYlDV&mc=B1&s=rWw5L&u=TgO&y=N&” Simply put, 20% of your customers generate 80% of your revenues (p-rofits) or 20% of your tasks generate 80% of the results. Or in our case:

20% of the trades we enter will bring 80% of gains.

KEEP READING, DON’T RUN! I am not saying that 80% of the trades are bad. I am saying that if you follow the rules I discuss in my lessons, some of the winners will carry you way further than any other winners. But most importantly it also means that the ones that don’t do well will not set you back as much as you would think.

It’s all about discipline and stop loss management.

Sounds simple Not really! It has everything to do with how well you stick to the plan and how you keep your emotions in check.  The Bottom Line Is That Discipline & Consistency Will Almost Always Keep You On Top.

With that being said, I hope you had a great weekend, Look for my alert later this evening and enjoy the rest of your day.

Sincerely, Anthony.

  Please read this disclaimer in full:  This report/release/advertisement is a commercial advertisement and is for general information and marketing purposes only. We are engaged in the business of marketing and advertising companies for compensation (monetary and/or equity). Never invest in any company stock featured on our site or emails unless you can afford to lose your entire inv est-ment. You should always consult with a financial professional before making any inv est-ment. The disclaimer is to be read and fully understood before using our website, or joining our email list. Full disclaimer can be read at one our website: PennyDoctor/disclaimer “https://app.getresponse.com/click..htmlx=a62b&lc=BYlDJ&mc=B1&s=rWw5L&u=TgO&y=7&” Release of lia-bility: Through use of this website or email viewing you agree to hold PennyDoctor, its operators owners and employees harmless and to completely release them from any and all lia-bility due to any and all loss (monetary or otherwise), da-mage (monetary or otherwise), or in-jury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not gua-ranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

PennyDoctor (or its affiliate) has received compensation from a non-affiliate third part-y Blanca Solutions, in the amount of two thousand, five hundred dollars for advertising services regarding CGrowth Capital, Inc. (CGRA) for a one day period. Such services include but are not limited to the preparation and publication of this profile, and so-cial media coverage. PennyDoctor receives the compensation amount as a production budget and it will retain as its fee for services rendered any and all amounts which exceed its actual costs of production, copy writing, and e-mailing and other distribution expenses. PennyDoctor has not directly or through third parties investigated CGrowth Capital, Inc. (CGRA) or its business, management, or control persons. CGrowthCapital.com provided all of the content contained in this email. Accordingly, our profile of CGrowth Capital, Inc. (CGRA) is, and it should be read, ONLY, as a paid advertisement which is neither unbiased nor independent, and you should consider this disclaimer when evaluating the contents of this profile.

In some instances, third parties (not the company profiled) engage our services. You should assume that any third part-y which engaged us in connection with this profile of CGrowth Capital, Inc. (CGRA), owns shares of the company AND may sell such shares in the public market, and that the sale of such shares may negatively impact the market price for the shares of the profiled company.

Third par-ty Website and Information: This site and email you receive may provide hyperlinks to third par-ty websites or ac-cess to third par-ty content. PennyDoctor does not control, endorse, or gua-rantee content found in such sites. You agree that PennyDoctor is not responsible for any content, associated links, resources, or services associated with a third par-ty site. You further agree that PennyDoctor shall not be liable for any loss or da-mage of any sort associated with your use of third par-ty content. Links and ac-cess to these sites are provided for your convenience only.

PennyDoctor encourages its readers to supplement this profile with independent research and professional financial advice. Our newsletter has relied upon information supplied by its customers, press releases, and other publicly available information which assumes is accurate in all material respects; however, such accuracy cannot be gua-ranteed. This advertisement does not constitute offers or solicitations to pur-chase or sell securities of the company profiled herein, and any decision to invest in any such company or other financial decisions should not be made based upon the content of this advertisement. Instead we strongly urge you conduct a complete and independent investigation of the company and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D, OTCmarkets .com, SEC .gov, FINRA .org, and Investor .gov.

Investing or trading in development stage micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. An entire inv est-ment may be lost or impaired due to the highly speculative nature of the company profiled.

PennyDoctor is an electronic publication, and it is published for informational purposes only. We do not undertake or purport to render inv est-ment advice or recommendations or solicitations for the b-u-ying and selling of securities. We are not, and we do not hold ourselves out to be, a registered broker or dealer or inv est-ment advisor or other licensed professional engaged in any jurisdiction in the securities, money management or inv est-ment business or any aspect thereof. Our website and our f-ree and subscription-based newsletters are not a solicitation to b-u-y or sell securities. Investing or trading in development stage micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. An entire inv est-ment may be lost or impaired due to the highly speculative nature of the company profiled.

This message was intended for You have received this message because you are subscribed to PennyDoctor.com https://app.getresponse.com/me.htmlx=a62b&m=aUS6&s=rWw5L&u=TgO&y=N&| To contact us please email newsletter@PennyDoctor.com  Powered by: https://app.getresponse.com/referral.htmlx=a62b&u=TgO&y=O& SGN Media Group, Inc, 366 N Broadway – Suite 410, Jericho, NY 11753, United States To

 

Related posts:

  1. CGRA – Pre Market Update
  2. Low Volume 8 cents spotlight for Monday
  3. * CGRA * is on immediate alert! Juicy details inside on my latest pick.
  4. Just Following up
  5. Have you been watching today?






You may also like...